Scientists Are Studying GLP-1s for Broader Health Benefits in Bipolar Disorder These include metabolic liver disease, polycystic ovary syndrome (PCOS), and binge eating disorder, says Roger McIntyre, MD, a professor of psychiatry and pharmacology at the University of Toronto and head of the Mood Disorders Psychopharmacology Unit of the University Health Network in Toronto
For patients with specific concerns about retatrutide and hair loss , dedicated guidance is also available
Choose the one thats best for you and print, text, or save it
Efficacy and safety of ITCA 650, a novel drug-device GLP-1 receptor agonist, in Type 2 diabetes uncontrolled with oral antidiabetes drugs: the FREEDOM-1 trial
However, its important to be aware that more serious risks, though rare, can occur
LncRNA is involved in the regulation of prognosis by modulating the infiltration and function of immune cells, as well as the metabolism and phenotype of tumor cells